CKM Syndrome Increases Cancer Risk by Up to 30%, New Study Shows

People with cardiovascular-kidney-metabolic (CKM) syndrome face a significantly higher risk of developing cancer, according to a new study published in Circulation: Population Health and Outcomes, a journal of the American Heart Association (AHA). The research highlights that cancer risk escalates with the severity of CKM syndrome, ranging from a 3% higher risk at stage 1 to a 30% higher risk at stage 4.

Key Findings from the Study

  • CKM syndrome severity correlates with cancer risk: The study found that as CKM syndrome progresses, the likelihood of developing cancer increases proportionally.
  • CKM syndrome affects 90% of U.S. adults: Researchers estimate that at least some components of CKM syndrome are present in 90% of adults in the United States.
  • Observational study with significant implications: While the research is observational and does not establish causality, it underscores the need for integrated risk assessment and prevention strategies.

“These findings suggest that CKM staging may help identify individuals at increased cancer risk, supporting a more holistic approach to risk stratification beyond cardiovascular outcomes.”

“These findings extend the clinical relevance of the CKM framework beyond cardiovascular and kidney outcomes, underscoring the need for integrated risk assessment and prevention in multimorbid individuals.”

Expert Reactions and Recommendations

Medical experts not involved in the study have weighed in on its significance. Michael McConnell, MD, a clinical professor of cardiovascular medicine at Stanford Medicine, noted that existing science already shows a strong overlap in risk factors for cardiovascular disease and cancer. He emphasized that this study adds to the growing body of evidence linking cardiovascular disease, metabolic dysfunction, and chronic kidney disease with cancer risk.

Christopher Berg, MD, a non-interventional cardiologist specializing in cardio-oncology at MemorialCare Heart and Vascular Institute at Orange Coast Medical Center in Fountain Valley, CA, acknowledged the study’s value in identifying at-risk patients. However, he pointed out that it does not provide specific treatment or prevention strategies beyond general health recommendations.

“This study may help identify at-risk patients but is less helpful in pointing toward a solution beyond a general recommendation to work toward better health to reduce the risk of future illness.”

— Christopher Berg, MD

Prevention Strategies for Reducing Cancer Risk in CKM Syndrome

Researchers and experts agree that lifestyle modifications can play a critical role in reducing cancer risk among individuals with CKM syndrome. Key recommendations include:

  • Maintaining a healthy diet rich in fruits, vegetables, and whole grains.
  • Engaging in regular physical exercise.
  • Avoiding alcohol and tobacco use.

Berg emphasized that prioritizing heart health is paramount, as improvements in cardiovascular health may also reduce cancer risk. He stated, “The chief health concerns of people with CKM should be to work to reduce their risk of cardiovascular disease, which will in turn reduce their risk of cancer. Broadly, if it is good for the heart, it will help reduce your risk of cancer as well.”

What Is CKM Syndrome?

Cardiovascular-kidney-metabolic (CKM) syndrome is a multifaceted health condition that encompasses a range of disorders affecting the heart, kidneys, and metabolism. It is characterized by the interplay of cardiovascular disease, chronic kidney disease, and metabolic conditions such as diabetes and obesity. The syndrome is classified into stages based on its severity, with higher stages indicating greater health risks.

The study’s authors argue that CKM staging could serve as a valuable tool for identifying individuals at higher risk of cancer, advocating for a more comprehensive approach to patient care that goes beyond traditional cardiovascular risk assessment.

Call for Integrated Risk Assessment and Prevention

The researchers behind the study advocate for integrating cancer prevention into the treatment protocols for individuals with CKM syndrome. They stress the importance of a holistic approach to patient care that addresses the interconnected risks of cardiovascular disease, kidney disease, and cancer. This approach, they argue, is essential for improving outcomes in multimorbid individuals who face multiple health challenges simultaneously.

The findings underscore the need for healthcare providers to adopt a broader perspective when assessing and managing the health risks of patients with CKM syndrome, ensuring that cancer prevention is given due consideration alongside other health priorities.

Source: Healthline